{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T12:20:57Z","timestamp":1795263657103,"version":"4.10.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,6]]},"DOI":"10.7759\/cureus.20979","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T08:58:05Z","timestamp":1641459485000},"source":"Crossref","is-referenced-by-count":7,"title":["COVID-19 Vaccine-Induced Pneumonitis, Myositis and Myopericarditis"],"prefix":"10.7759","author":[{"given":"Mariya","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoor","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawpadee","family":"Dharmasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman Iqbal","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osei","family":"Kankam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO. Coronavirus disease (COVID-19). vaccines. (2021). https:\/\/www.who.int\/news-room\/q-a-detail\/coronavirus-disease-(covid-19)-vaccines?topicsurvey=v8kj13)&amp;gclid=Cj0KCQjw4I...."},{"key":"ref2","unstructured":"Oxford\/AstraZeneca Covid vaccine research \u2018was 97% publicly funded\u2019. The Guardian. (2021). https.\/\/www.theguardian.com\/science\/2021\/apr\/15\/oxfordastrazeneca-covid-vaccine-research-was-97-publicly-funded."},{"key":"ref3","unstructured":"UK government grants Pfizer civil legal indemnity for COVID-19 vaccine. Jurist. (2020). https.\/\/www.jurist.org\/news\/2020\/12\/uk-government-grants-pfizer-civil-legal-indemnity-for-covid-19-vaccine\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-016-0114-4","article-title":"Post-vaccination myositis and myocarditis in a previously healthy male","volume":"12","author":"Cheng MP","year":"2016","unstructured":"Cheng MP, Kozoriz MG, Ahmadi AA, Kelsall J, Paquette K, Onrot JM. Post-vaccination myositis and myocarditis in a previously healthy male. Allergy Asthma Clin Immunol. 2016, 12:6. 10.1186\/s13223-016-0114-4","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2021-140564","article-title":"Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study","author":"Zafar M","year":"2021","unstructured":"Zafar M, Karkhanis M, Shahbaz M, et al.. Vitamin D levels and mortality with SARS-COV-2 infection: a retrospective two-centre cohort study. Postgrad Med J. 2021, 10.1136\/postgradmedj-2021-140564","journal-title":"Postgrad Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16554","article-title":"A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?","volume":"13","author":"Zafar M","year":"2021","unstructured":"Zafar M, Shahbaz M, Karkhanis M, et al.. A retrospective observational study: is absolute lymphocyte count a prognostic marker in COVID-19?. Cureus. 2021, 13:e16554. 10.7759\/cureus.16554","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05463-x","article-title":"A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection","volume":"64","author":"Ruan Y","year":"2021","unstructured":"Ruan Y, Ryder RE, De P, et al.. A UK nationwide study of people with type 1 diabetes admitted to hospital with COVID-19 infection. Diabetologia. 2021, 64:1717-24. 10.1007\/s00125-021-05463-x","journal-title":"Diabetologia"},{"key":"ref8","article-title":"Can HbA1c levels be used as an independent marker of mortality and morbidity risk in patients with COVID19 positive swabs? - a retrospective observational study","volume":"98","author":"Zafar M","year":"2021","unstructured":"Zafar M, Randhawa R S, Hegner W, et al.. Can HbA1c levels be used as an independent marker of mortality and morbidity risk in patients with COVID19 positive swabs? - a retrospective observational study. Univ Tor Med J. 2021, 98:[Epub].","journal-title":"Univ Tor Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15490","article-title":"COVID-19 vaccination-induced rash: does the choice of vaccine matter?","volume":"13","author":"Zafar M","year":"2021","unstructured":"Zafar M, Ewnetu B, Ahmed S, Iqbal U, Whitehead M. COVID-19 vaccination-induced rash: does the choice of vaccine matter?. Cureus. 2021, 13:e15490. 10.7759\/cureus.15490","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081599","article-title":"Thrombocytopenia and intracranial venous sinus thrombosis after \"COVID-19 vaccine AstraZeneca\" exposure","volume":"10","author":"Wolf ME","year":"2021","unstructured":"Wolf ME, Luz B, Niehaus L, Bhogal P, B\u00e4zner H, Henkes H. Thrombocytopenia and intracranial venous sinus thrombosis after \"COVID-19 vaccine AstraZeneca\" exposure. J Clin Med. 2021, 10:1599. 10.3390\/jcm10081599","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.027","article-title":"Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2","volume":"182","author":"Jiang RD","year":"2020","unstructured":"Jiang RD, Liu MQ, Chen Y, et al.. Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2. Cell. 2020, 182:50-58.e8. 10.1016\/j.cell.2020.05.027","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcab043","article-title":"COVID-19 vaccine-related myositis","volume":"114","author":"Theodorou DJ","year":"2021","unstructured":"Theodorou DJ, Theodorou SJ, Axiotis A, Gianniki M, Tsifetaki N. COVID-19 vaccine-related myositis. QJM. 2021, 114:424-5. 10.1093\/qjmed\/hcab043","journal-title":"QJM"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6711","article-title":"Paraspinal myositis in patients with COVID-19 infection","volume":"41","author":"Mehan WA","year":"2020","unstructured":"Mehan WA, Yoon BC, Lang M, Li MD, Rincon S, Buch K. Paraspinal myositis in patients with COVID-19 infection. AJNR Am J Neuroradiol. 2020, 41:1949-52. 10.3174\/ajnr.A6711","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27003","article-title":"COVID-19-associated myositis with severe proximal and bulbar weakness","volume":"62","author":"Zhang H","year":"2020","unstructured":"Zhang H, Charmchi Z, Seidman RJ, Anziska Y, Velayudhan V, Perk J. COVID-19-associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020, 62:E57-60. 10.1002\/mus.27003","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102205","article-title":"COVID-19 vaccine-induced myocarditis: case report with literature review","volume":"15","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Gonzalez C, et al.. COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes Metab Syndr. 2021, 15:102205. 10.1016\/j.dsx.2021.102205","journal-title":"Diabetes Metab Syndr"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.carrev.2021.08.012","article-title":"Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review","volume":"[Epub ahead of print]","author":"Sulemankhil I","year":"2021","unstructured":"Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19 Ad26.COV2.S vaccine and acute myocarditis: a case report and literature review. Cardiovasc Revasc Med. 2021, [Epub ahead of print]:10.1016\/j.carrev.2021.08.012","journal-title":"Cardiovasc Revasc Med"},{"key":"ref17","unstructured":"COVID-19 vaccination. a guide to booster vaccination - GOV.UK. (2021). https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccination-booster-dose-resources\/covid-19-vaccination-a-guide-t...."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1116","article-title":"Covid-19: booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses","volume":"373","author":"Mahase E","year":"2021","unstructured":"Mahase E. Covid-19: booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses. BMJ. 2021, 373:1116. 10.1136\/bmj.n1116","journal-title":"BMJ"},{"key":"ref19","unstructured":"FDA clears first covid antibody treatment for immunocompromised before exposure. NBC News. (2021). https.\/\/www.nbcnews.com\/health\/health-news\/fda-clears-astrazenecas-covid-antibody-treatment-immunocompromised-rcna8130."},{"key":"ref20","unstructured":"Pfizer covid pill approved In UK for those most at risk. The Independent. (2021). https.\/\/www.independent.co.uk\/news\/uk\/home-news\/paxlovid-covid-pill-pfizer-uk-b1984885.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/82331-covid-19-vaccine-induced-pneumonitis-myositis-and-myopericarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:06Z","timestamp":1707507306000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/82331-covid-19-vaccine-induced-pneumonitis-myositis-and-myopericarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.20979","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,6]]}}}